α and 1–β [Power / Sample Size]

posted by Yura – Belarus, 2017-12-28 06:50 (1391 d 15:25 ago) – Posting: # 18108
Views: 30,747

Hi Helmut,

» Although the study was performed with 28 subjects for ~81% power, the chance to get a post hoc power of ≥ 90% is ~23% and ≥ 95% is ~10%. That’s clearly not “forced BE” and none of these studies should be questioned by regulators.

You are considering the power after the study at n = 28 (which were calculated before the study: GMR=0.95, CV=0.25, β=0.80). The question is whether it is possible to carry out a study at n = 50 and will this be forced bioequivalence?
Regards

Complete thread:

Activity
 Admin contact
21,743 posts in 4,546 threads, 1,543 registered users;
online 24 (0 registered, 24 guests [including 3 identified bots]).
Forum time: Tuesday 23:15 CEST (Europe/Vienna)

Sometimes the key to an answer is found
in the way you formulate the question.    David Brin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5